<DOC>
	<DOCNO>NCT01239888</DOCNO>
	<brief_summary>The purpose study determine whether oxytocin ad-on , oxytocin tibolone ad-on induce response antidepressants patient treatment resistant depression .</brief_summary>
	<brief_title>Oxytocin Tibolone Adjuncts Treatment Resistant Depression - A Pilot Study</brief_title>
	<detailed_description>We examine efficacy safety oxytocin oxytocin tibolone antidepressant ( SSRIs ) treatment resistant depression double-blind randomize clinical trial . A secondary objective evaluation neurobiological factor contribute drug efficacy treatment resistant depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Tibolone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Bone Density Conservation Agents</mesh_term>
	<criteria>Women 1845 year Current DSMIV diagnosis Major Depression Comorbid anxiety disorder secondary depression include Past history least 2 fail treatment response ( include SSRIs ) high tolerate dose least 46 week A MADRS score &gt; 20 randomization Women stable dose SSRI ( sertraline , citalopram , escitalopram , paroxetine , fluoxetine fluvoxamine ) least 46 week . A negative pregnancy test screen A clinically acceptable Pap smear within past 2 year Must able use intranasal spray swallow tablet Patients may take 2 sleep medication permit dose consider reasonable investigate team . Limited adjustment sleep medication acceptable . Patients ask notify researcher change sleep medication . Any previous history adverse sideeffects escitalopram ( SSRI ) Use oral contraceptive ( hormonal method contraception ) duration study DSMIV define substance dependence , history bipolar disorder , schizoaffective disorder schizophrenia Significant unstable medical illness include epilepsy , diabetes cardiac relate , renal liver disease , hormone dependent cancer pregnancy A BMI &lt; 18 &gt; 34kg/m2 Planning pregnancy Renal disease , history cerebrovascular disease , thromboembolic disorder , myocardial infarction angina time study entry thrombophlebitis within last 5 year , major illness occur within last 6 month . An undiagnosed genital bleed Moderate severe acne hirsutism , use antiandrogen therapy acne hirsutism precede 5 year , androgenic alopecia ( exclude woman clinically meaningful androgen excess ) Active malignancy , treatment malignancy precede 6 month ( exclude nonmelanotic skin cancer ) Alcohol consumption excess 3 standard drink per day Lactose intolerance An abnormal thyroid stimulate hormone ( TSH ) value screen confirm Free T4 outside normal laboratory range ( patient abnormal TSH , normal Free T4 clinical sign symptom thyroid disease , without replacement treatment , may admit study ) . A history allergic reaction androgen ( oral patch ) Chronic medication : aspirin warfarin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Depression</keyword>
	<keyword>Treatment resistant depression</keyword>
	<keyword>Oxytocin</keyword>
	<keyword>Estrogen Modulators</keyword>
	<keyword>HPA axis</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Estrogens</keyword>
	<keyword>Tibolone</keyword>
	<keyword>Estrogen Receptor Modulators</keyword>
	<keyword>Androgens</keyword>
	<keyword>Hormones</keyword>
	<keyword>Hormone Substitutes</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Hormone Antagonists</keyword>
	<keyword>Bone Density Conservation Agents</keyword>
	<keyword>Estrogen Antagonists</keyword>
</DOC>